新座標(603040.SH):股東任海軍、楊琦蘋提前完成減持計劃
格隆匯5月5日丨新座標(603040.SH)公佈,2025年4月3日,公司在上海證券交易所網站披露了《新座標董監高減持股份計劃公告》,公司董事任海軍、監事楊琦蘋、副總經理兼董事會祕書鄭曉玲出於自身資金需求,計劃以集中競價交易減持不超過99,348股,減持比例不超過總股本的0.0728%。
2025年4月30日,公司收到任海軍、楊琦蘋出具的《關於減持新座標股份結果情況告知函》。截至公告披露日,任海軍減持公司股份18,200股、楊琦蘋減持公司股份3,700股,提前完成本次減持計劃。公司副總經理兼董事會祕書鄭曉玲未減持其持有的公司股份,後續將嚴格按照減持計劃實施減持並履行相應的信息披露義務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.